Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T14:35:32.645Z Has data issue: false hasContentIssue false
  • English
  • Français

Ethical Analysis of Communicating the Risk of Iatrogenic Creutzfeldt-Jakob Disease

Published online by Cambridge University Press:  02 January 2015

David I. Shalowitz ,
Andrew Barnosky  and
Lauren Barrett Smith
David I. Shalowitz*
Affiliation:
Bioethics Program, University of Michigan Medical School, Ann Arbor, Michigan
Andrew Barnosky
Affiliation:
Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, Michigan
Lauren Barrett Smith
Affiliation:
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
*
Bioethics Program, University of Michigan, Ann Arbor, MI 48109 (dshalowi@med.umich.edu)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 30 , Issue 8 , August 2009 , pp. 805 - 806
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Sutton, JM, Dickinson, J, Walker, JT and Raven, ND. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard? Clin Infect Dis 2006;43:757–764.CrossRefGoogle ScholarPubMed
2.Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts—Japan, 1978-2008. MMWR Morb Mortal Wkly Rep 2008;57:1152–1154.Google Scholar
3.Centers for Disease Control and Prevention (CDC). CJD (Creutzfeldt-Jakob disease, classic). Information on Creutzfeldt-Jakob disease for funeral home, cemetery, and crematory practitioners. Available at: http://www.cdc.gov/ncidod/dvrd/cjd/funeral_directors.htm. Accessed June 15, 2009.Google Scholar
4.Mahillo-Fernandez, I, de Pedro-Cuesta, J, Bieda, MJ, et al.Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 2008;31:229–240.CrossRefGoogle ScholarPubMed
5.Fichet, G, Comoy, E, Duval, C, et al.Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004;364:521–526.CrossRefGoogle ScholarPubMed
6.Taylor, DM. Inactivation of prions by physical and chemical means, J Hosp Infect 1999;43 Suppl:S69–S76.CrossRefGoogle ScholarPubMed
7.Damschroder, LJ, Zikmund-Fisher, BJ, Ubel, PA. Considering adaptation in preference elicitations. Health Psychol 2008;27:394–399.CrossRefGoogle ScholarPubMed
8.Broadstock, M, Michie, S, Marteau, T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000;8:731–738.Google Scholar
9.Amalberti, R, Auroy, Y, Berwick, D, Barach, P. Five system barriers to achieving ultrasafe health care. Ann Intern Med 2005;142:756–764.CrossRefGoogle ScholarPubMed